EN
podcaster image

Gratitude Geek

Kandas Rodarte

Gratitude Geek is the podcast for micropreneurs building genuine lasting relationships with clients, colleagues and community. Listen for weekly interviews with inspirational business owners who built their brand and their business with gratitude and appreciation. Hosted by digital marketing pioneer, breast cancer thriver and productivity coach, Kandas Rodarte. Join us on our mission to spread gratitude, sow seeds of appreciation, and harvest a bounty of generosity and kindness.

Episode

Most women don’t find out what breast cancer support resources are available until they’re already in crisis. In this episode, Kandas sits down with Gretchen Awad, Executive Director of Susan G. Komen Northwest Ohio and Detroit, for an honest conversation about what Komen actually does on the ground — and how to access it.

Full show notes + resources: https://kandasrodarte.com/315

Gretchen walks through Komen’s four pillars — advocacy, research, financial assistance, and community education — and explains how to get help regardless of your zip code or financial situation. She’s joined by Dr. Michelle D. Clark, a breast cancer survivor and board member for Susan G. Komen Detroit, whose own story brings the human side of everything Komen exists to do.

Because this is Gratitude Geek, we also dig into something the medical community rarely talks about — how gratitude functions as a survival tool when your world has been turned upside down.

This episode is part of Podcasthon, an international movement where podcasters around the globe spotlight their charity of choice during the same week.

Resources mentioned:

Home


https://cancer.org
https://podcasthon.org

Learn more about your ad choices. Visit megaphone.fm/adchoices

The charity and its cause

association image

Susan G Komen

Forty-two years ago, a sisterly promise ignited a spark that would fuel a global crusade against breast cancer. Today that promise continues to prevail as the driving force behind Susan G. Komen’s unwavering quest for a future free from the grip of this deadly disease. In the pursuit of our goals, we’ve helped fuel research, unlocking the biology of breast cancer and discovering insights that propel us toward more effective risk reduction strategies, earlier detection methods and innovative treatments. This helped reduce breast cancer mortality by more than 42%. To date, we’ve invested nearly $3.6 billion in groundbreaking research, community health outreach, advocacy and programs in more than 60 countries. Due to investments in research, 19 new drugs for breast cancer were approved in the past decade, and Komen is proud to have been a catalyst for these discoveries. We stand firm in our promise to never give up on our vision of creating a world without breast cancer.